| Literature DB >> 35854750 |
Alaleh Azhir1, Soheila Talebi2, Louis-Henri Merino3, Yikuan Li1, Thomas Lukasiewicz1, Edgar Argulian2, Jagat Narula2, Borislava Mihaylova1,4.
Abstract
Incorporating repeated measurements of vitals and laboratory measurements can improve mortality risk-prediction and identify key risk factors in individualized treatment of COVID-19 hospitalized patients. In this observational study, demographic and laboratory data of all admitted patients to 5 hospitals of Mount Sinai Health System, New York, with COVID-19 positive tests between March 1st and June 8th, 2020, were extracted from electronic medical records and compared between survivors and non-survivors. Next day mortality risk of patients was assessed using a transformer-based model BEHRTDAY fitted to patient time series data of vital signs, blood and other laboratory measurements given the entire patients' hospital stay. The study population includes 3699 COVID-19 positive (57% male, median age: 67) patients. This model had a very high average precision score (0.96) and area under receiver operator curve (0.92) for next-day mortality prediction given entire patients' trajectories, and through masking, it learnt each variable's context. ©2022 AMIA - All rights reserved.Entities:
Mesh:
Year: 2022 PMID: 35854750 PMCID: PMC9285184
Source DB: PubMed Journal: AMIA Annu Symp Proc ISSN: 1559-4076